LAS VEGAS, NV (September 25, 2017)—BOOTH# NN179—Mineral BioSciences (MBS), a leading manufacturer of nutrient-rich mineral health solutions, is positioned to continue providing innovative manufacturers across multiple industries who see the competitive advantage to add a chelator and enhance their product’s bioavailability with its unique and patented ingredient, Ioniplex®. MBS is showcasing Ioniplex at this year’s SupplySide West Expo on September 25-29 in Mandalay Bay, Las Vegas, NV.
What is Ioniplex? Ioniplex is an active fulvic ionic mineral complex that contains up to 65 essential macro, micro, and trace minerals. It is highly bioavailable–basically boosting the absorption of nutrients in the body–and, as a fulvic acid, penetrates membranes and cellular barriers to deliver full impact to metabolic sites within cells. What makes Ioniplex an ideal addition to a product formulation is that it acts as a detoxifier, by chelating and removing heavy metals and neutralizing free radicals within the cellular structure thus protecting the body’s cells from further damage. Its power and potency are substantiated by independent clinical studies, which found that Ioniplex helps improve cellular activity, promotes healthier glucose metabolism, reduces cellular degradation, increases energy performance and optimization, and promotes proper digestion and utilization of nutrients.*
“Protecting and maintaining healthy cells is a key element to a healthy lifestyle and Ioniplex is a safe and highly bioavailable key ingredient that has been clinically shown to help protect cells and improve cellular energy and vitality to the thirty-seven trillion plus cells in our bodies,” says Luke Blotsky, CEO of MBS. “Bottled in liquid form or dehydrated into a water-soluble powder, Ioniplex is an attractive addition to a broad spectrum of products, including dietary supplements, beverage and functional food, sports nutrition, and skin and personal care products, especially those with a focus on cellular health.”*
At this year’s SupplySide West, Ioniplex is likely to gain prominence among skin and personal care manufacturers looking capitalize in the industry’s continued growth, which is projected to reach $25 billion by 2025. As a key ingredient, Ioniplex helps to stimulate collagen production, increase antioxidant activity, protect against inflammation, boost cell turnover, absorb and retain moisture, and enhance skin structure, strength, and recovery.
Learn more about Ioniplex and how it can boost your product formulation at SupplySide West Expo, Booth # NN179 or visit www.mineralbiosciences.com. To speak with MBS Business Manager, Rich Hunsaker, please contact Sarah Van Wyk at email@example.com.
Ioniplex comes from ancient mineraloid deposits from select sites within the United States where lush vegetation once grew, millions of years ago. Mineral Biosciences finds and extracts these naturally-occurring minerals with a patented process that uses no chemicals. Scientific research has shown that Ioniplex helps support healthy blood sugar levels, cellular protection and mitochondrial metabolism.
Mineral Biosciences® (MBS) is a leading manufacturer of natural, fulvic ionic mineral extracts. MBS is an affiliate of the larger Global Organics® Group of companies. Founded over 40 years ago with the leading principal “Nature Knows Best®,” Global Organics Group has developed signature mineral products proven to enhance the health of people, animals, and the environment.
SupplySide West brings together more than 15,000 ingredient buyers and suppliers from the dietary supplement, beverage, functional food, personal care and sports nutrition industries. SupplySide West is all about the science and strategy around the development of finished products that drive the global business economy. Join us this year to learn about new trends from over 1,200 exhibitors and 140 hours of educational and conference programming.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.